Market Chatter: GSK Commences Six-Part Dollar Bond Sale to Help Fund Nuvalent Acquisition

09:13 AM EDT, 09/08/2026 (MT Newswires) -- GSK (GSK) has kicked off a six-tranche dollar bond sale to help refinance bridge funding for its $10.6 billion acquisition of Nuvalent, Bloomberg reported Tuesday, citing a person familiar with the matter. The six-part offering has bonds with maturities ranging from three to 30 years, with initial price talks for the longest tenor for a premium of about 1.1 percentage points above Treasuries, the report said, citing the person. Bank of America (BAC), BNP Paribas, Citigroup (C), JPMorgan Chase (JPM) and Morgan Stanley (MS) are managing the sale, the person reportedly told Bloomberg. GSK didn't immediately reply to a request for comment from MT Newswires. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)